Back to Pediatrics
Pediatricsv2024Evidence-Based

Intrauterine RBC Transfusion Dosage

Estimates volume of donor RBCs needed for intrauterine transfusion (IUT) in fetal anemia cases. Used primarily for severe fetal anemia in hemolytic disease of the fetus and newborn (HDFN) when maternal RBC alloantibodies threaten fetal health. Calculates precise transfusion volume to achieve target hematocrit while minimizing risks of over- or under-transfusion.

Clinical Input Parameters

g
Range: 200 — 5000 g
%
Range: 5 — 60 %
%
Range: 25 — 60 %
%
Range: 60 — 90 %
Clinical Assessment
Awaiting Parameters
transfusion volume
—mL
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Intrauterine RBC Transfusion Dosage is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Transfusion volume (mL) = Fetoplacental volume × [Hct(goal) - Hct(initial)] / Hct(transfused); Fetoplacental volume = fetal weight (g) × 0.14 mL/g

Clinical Pearls & Practice Notes

  • Used primarily for hemolytic disease of the fetus and newborn (HDFN) due to maternal alloantibodies
  • Target post-IUT hematocrit is typically 40-45%
  • Fetoplacental volume estimated as 14% of fetal weight (0.14 mL/g)
  • Donor RBCs should be CMV-negative, irradiated, and compatible with maternal serum
  • Requires specialized maternal-fetal medicine expertise and ultrasound guidance
  • Monitor for complications including fetal bradycardia, bleeding, and infection
  • Consider serial transfusions for severe cases or if single transfusion volume is excessive

Evidence & Literature Citations

  1. Mandelbrot L, Daffos F, Forestier F, MacAleese J, Descamps P. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther. 1988;3(1-2):60-6.
  2. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J. 1963;2(5365):1107-9.
  3. Society for Maternal-Fetal Medicine (SMFM). Management of alloimmunization during pregnancy. Am J Obstet Gynecol. 2018;218(2):B7-B18.
  4. Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171-7.

Score Interpretation Ranges

Small Volume0 – 20 pts

Small transfusion volume

Moderate Volume20 – 60 pts

Moderate transfusion volume

Large Volume60 – 200 pts

Large transfusion volume

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.